AMPLAMIX
Live / Allowed — Published for opposition (as of 17 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 21 Jul 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99293711
- Mark type
- Stylized text
- Filed
- 21 Jul 2025
- Published for opposition
- 17 Mar 2026
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 001 — Chemicals: Assays for research purposes
- Class 005 — Pharmaceuticals: Medical diagnostic reagents and assays for testing of bodily fluids; medical diagnostic assays for bodily fluid testing for diagnosing Alzheimer’s disease, neurological conditions, auto-immune diseases, and cancer; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, Alzheimer’s disease, neurological conditions, auto-immune diseases, and cancer
- Class 010 — Medical apparatus: Medical diagnostic kits consisting primarily of probes, buffers and reagents for use in testing protein biomarkers for Alzheimer's disease, neurological conditions, auto-immune diseases, and cancer
Owner
- Taudia, Inc., San Carlos,, CA, US
- Taudia, Inc., San Carlos,, CA, US
Prosecution history
- 17 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Mar 2026 — PUBLISHED FOR OPPOSITION
- 11 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Dec 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 Dec 2025 — NON-FINAL ACTION E-MAILED
- 08 Dec 2025 — NON-FINAL ACTION WRITTEN
- 08 Dec 2025 — ASSIGNED TO EXAMINER
- 25 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 21 Jul 2025 — APPLICATION FILING RECEIPT MAILED
- 21 Jul 2025 — NEW APPLICATION ENTERED